370results about How to "Improve clinical outcomes" patented technology

Methods and apparatus for patient care detect a current medical condition of a patient receiving medical treatment, e.g., by sensing blood pressure, heart rate, weight, glucose level, hemoglobin level, and / or blood potassium level (all by way of example) and transmit information regarding that medical condition to a digital data processing system disposed remotely from the medical treatment apparatus. The medical treatment apparatus can be, for example, one for peritoneal dialysis and hemodialysis, and the medical condition can be sensed by sensors coupled to or otherwise utilized in connection with such apparatus.

A method of treating a tumor includes providing a tissue biopsy and treatment apparatus that includes an elongated delivery device that has a lumen and is maneuverable in tissue. A sensor array having a plurality of resilient members is deployable from the elongated delivery device. At least one of the plurality of resilient members is positionable in the elongated delivery device in a compacted state and deployable with curvature into tissue from the elongated delivery device in a deployed state. At least one of the plurality of resilient members includes at least one of a sensor, a tissue piercing distal end or a lumen. The sensor array has a geometric configuration adapted to volumetrically sample tissue at a tissue site to differentiate or identify tissue at the tissue site. At least one energy delivery device is coupled to one of the sensor array, at least one of the plurality of resilient members or the elongated delivery device. The apparatus is then introduced into a target tissue site. The sensor array is then utilized to distinguish a tissue type. The tissue type information derived from the sensor array is utilized to position the energy delivery device to ablate a tumor volume. Energy is then delivered from the energy delivery device to ablate or necrose at least a portion of the tumor volume. The sensor array is then utilized to determine an amount of tumor volume ablation.

A motion interface structure for use with a pedicle screw is provided, the motion interface structure defining a central passage having an internal face. A helical thread is formed on at least a portion of the internal face of the central passage. The motion interface element is designed to cooperate with an upstanding region of a pedicle screw. The upstanding region includes a threaded region that is adapted to threadingly engage the helical thread associated with the motion interface element. The motion interface element may take the form of a spherical element or a universal joint mechanism. The pedicle screw and motion interface element may be incorporated into a spinal stabilization system that includes one or more additional pedicle screw / motion interface element subassemblies. The spinal stabilization system may also include a dynamic stabilizing element that provides clinically efficacious results.

A pedicle screw assembly is provided that includes a pedicle screw and a preloaded set screw. The set screw is preloaded in a threaded, central aperture formed in the head region of the pedicle screw. An interference is advantageously formed on the set screw to prevent dislodgement of the set screw, e.g., during shipment and / or clinical placement of the pedicle screw. An upwardly extending collet is generally formed in the head region of the pedicle screw, the collet being sized to receive a spherical element therearound. Advancement of the set screw relative to the pedicle screw secures the spherical element relative to the pedicle screw. The spherical element typically includes a socket member that cooperates with a dynamic stabilizing member. The pedicle screw assembly and dynamic stabilizing member are advantageously used as part of a spinal stabilization system to provide clinically efficacious results.

Data from a plurality of sensors representing a patient's condition, including measurement signals and also secondary parameters derived from the measurement signals, are displayed in a simple way by calculating a novelty index constituting a one-dimensional visualization space. The novelty index is based on the distance of the current data point in a multi-dimensional measurement space, whose coordinates are defined by the values of the measurement signals and secondary parameters, from a predefined normal point. This may be achieved by using a suitably trained artificial neural network to sum the distance between the current data point in the measurement space and a plurality of prototype points representing normality.

A pedicle screw is provided that includes an upwardly extending collet. The collet may include downwardly extending slots that define deflectable segments therebetween. When a spherical element or other structure, e.g., a non-dynamic stabilizing element, is positioned around the collet, introduction of a set screw causes outward deflection of the upstanding segments into engagement with the spherical element. A snap ring may be interposed between the collet and the spherical element to facilitate positioning therebetween. In an alternative embodiment, a non-slotted collet is employed. In such embodiment, the collet and the spherical element may be threadingly engaged and may include a snap ring therebetween. The pedicle screw subassemblies may be incorporated into a spinal stabilization system which may include a dynamic stabilizing member to provide clinically efficacious results.

A cutting tool to be utilized in the resection or removal of bone tissue from patients includes a handle that tensions a wire or cable-like cutting member with a small diameter between at least two features on the handle to present a thin cutting profile. The design of the cutting tool includes features that protect against soft tissue damage and minimize the incision size necessary to utilize the tool. Some embodiments feature details of the cutting tool that interface with a surgical cutting guide system. Other embodiments describe a cutting tool with a selectively changeable length of the cutting profile of the wire cutting member. In one embodiment, the wire cutting member of the cutting tool is energized by mechanical energy in the form of a unidirectional rotation of the cutting member, a mechanical vibration of the cutting member, or an oscillating movement of the wire cutting member.

The present invention provides systems and methods for the evaluation of the urethra and periurethral tissues using an MRI coil adapted for insertion into the male, female or pediatric urethra. The MRI coil may be in electrical communication with an interface circuit made up of a tuning-matching circuit, a decoupling circuit and a balun circuit. The interface circuit may also be in electrical communication with a MRI machine. In certain practices, the present invention provides methods for the diagnosis and treatment of conditions involving the urethra and periurethral tissues, including disorders of the female pelvic floor, conditions of the prostate and anomalies of the pediatric pelvis.

Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.

Methods and systems for delivery of digital data in connection with medical treatment and patient care include detecting a current medical condition of a patient receiving medical treatment and delivering electronic informational data to the patient over a network. The informational data can be selected for delivery based on the current medical condition of the patient. The informational data can includes a plurality of informational data content options, and the patient can choose one or more of the informational data content options for delivery to the patient over the network. The chosen content can be displayed to the patient on a digital data display device, such as a touch screen monitor.

Implants are associated with a combination of paclitaxel or derivatives and dipyridamole or derivatives in order to inhibit fibrosis that may otherwise occur when the implant is placed within an animal. Exemplary implants include intravascular implants (e.g., coronary and peripheral vascular stents, catheters, balloons), non-vascular stents, pumps and sensors, vascular grafts, perivascular devices, implants for hemodialysis access, vena cava filters, implants for providing an anastomotic connection, electrical devices, intraocular implants, and soft tissue implants and fillers.

A method of treating a tumor includes providing a tissue biopsy and treatment apparatus that includes an elongated delivery device that has a lumen and is maneuverable in tissue. A sensor array having a plurality of resilient members is deployable from the elongated delivery device. At least one of the plurality of resilient members is positionable in the elongated delivery device in a compacted state and deployable with curvature into tissue from the elongated delivery device in a deployed state. At least one of the plurality of resilient members includes at least one of a sensor, a tissue piercing distal end or a lumen. The sensor array has a geometric configuration adapted to volumetrically sample tissue at a tissue site to differentiate or identify tissue at the tissue site. At least one energy delivery device is coupled to one of the sensor array, at least one of the plurality of resilient members or the elongated delivery device. The apparatus is then introduced into a target tissue site. The sensor array is then utilized to distinguish a tissue type. The tissue type information derived from the sensor array is utilized to position the energy delivery device to ablate a tumor volume. Energy is then delivered from the energy delivery device to ablate or necrose at least a portion of the tumor volume. The sensor array is then utilized to determine an amount of tumor volume ablation.

A system for monitoring patient activity comprising: at least one measurement device configured to provide data related to a patient's physical activity; and a server configured to make an inference regarding the patient's physical activity based on data provided by the at least one measurement device. In some embodiments, the inference is a determination of a type of physical activity. In some embodiments, the measurement device is configured to be worn by the patient or carried in the patient's pocket. In some embodiments, two or more measurement devices are used. In some embodiments, the server is remotely located from the measurement device. In some embodiments, the server is configured to archive and retrieve the data provided by the measurement device and the inferences.

The present invention describes a method that is operative within a clinical environment in which real-time locations of personnel and resources are tracked. The method begins in association with entry of a patient into the clinical environment, such as when a patient is in transit, or has been admitted, to an emergency room or to a hospital. In response, a given care guideline is identified. Using the care guideline, a set of one or more process rules, and information associated with at least one “encounter,” the system generates a patient-specific care protocol; the protocol includes a set of steps through which the patient is expected to proceed while in the clinical environment. An encounter occurs when two or more of objects (e.g., the patient, clinical personnel, and a clinical resource) are in a given physical proximity for a given time period at determined by the at least one process rule. According to the method, at least one event that occurs during at least a first step of the patient-specific care protocol is then monitored. Using information generated by the monitoring step and at least one process rule, the system then determines whether the patient moves to a next step in the patient-specific care protocol.

Hibernating myocardium is characterized by viable myocardium with impaired function due to localized reduced perfusion. Hibernating myocytes retain cellular integrity, but cannot sustain high-energy requirements of contraction. High plasma levels of catecholamines, such as norepinepherine, are believed to be predictive of mortality from hibernating myocardium. Likewise, high levels of catecholamines lead to cardiomyopathy in patients with diabetes. GLP-1 reduces plasma norepinepherine levels, and it thus is useful in a method of treating hibernating myocardium or diabetic cardiomyopathy.

The invention relates generally to the field of cancer prognosis and treatment. More particularly, the present invention relates to methods and compositions that utilize a particular panel of gene products (“biomarkers”) and their differential expression patterns (“expression signatures”), wherein the expression patterns correlate with responsiveness, or lack thereof, to chemotherapy treatment. The invention is based on the identification of a specific set of biomarkers that are differentially expressed in chemotherapy-treated tumors and which are useful in predicting the likelihood of a therapeutic response, including residual disease persistence and subsequent tumor recurrence in cancer patients receiving chemotherapy. The gene panel is also useful in designing specific adjuvant modalities with improved therapeutic efficiency. Also disclosed are methods for characterizing tumors according to expression of the biomarkers described herein.

A method of inserting and positioning an intervertebral spacer is provided. The spacer includes a longitudinal axis, an on-axis interface coincident with or parallel to the longitudinal axis, and an off-axis interface angled to the longitudinal axis. The spacer's front end may be curved. The method may include inserting the spacer into the disc space utilizing a tool to engage an on-axis interface and then to engage one or more of the off-axis interfaces, which may be used for further modification of the spacer. The tool is moved substantially along a single insertion direction, which may be substantially parallel to a posterior-anterior axis of the disc space. The method may result in the longitudinal axis of the spacer being perpendicular to the insertion direction, or substantially parallel to a medial-lateral axis of the disc space. The spacer may also be positioned in an anterior aspect of the disc space.

A sampling hub directs a medical device towards a target area. The hub may have some of: a hub body; a lumen passing between openings at the front end and the rear end, the lumen allowing for passage of an elongate element through the entire lumen; the bottom of the hub body may be flat; the top of hub body preferably is sloped downwardly; the lumen is preferably sloped downwardly to enable guidance of the elongate body towards the target area; and an area surrounding the opening of the lumen at the rear end configured to receive a support for the elongate element, the support for the elongate element having a diameter in the support larger than a diameter of the elongate element.

Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—.R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R5-R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2-C6 substituted or unsubstituted alkylene group.Z is ═O or ═S.Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with taxol or an analog of taxol.

Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C═Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(R7R8)—.R1 and R2 are independently an aryl group or a substituted aryl group, R3 and R4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R5–R6 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group.R7 and R8 are each independently —H, an aliphatic or substituted aliphatic group, or R7 is —H and R8 is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2–C6 substituted or unsubstituted alkylene group.Z is ═0 or ═S.Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent.Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with taxol or an analog of taxol.

A cutting tool to be utilized in the resection or removal of bone tissue from patients includes a handle that tensions a wire or cable-like cutting member with a small diameter between at least two features on the handle to present a thin cutting profile. The design of the cutting tool includes features that protect against soft tissue damage and minimize the incision size necessary to utilize the tool. Some embodiments feature details of the cutting tool that interface with a surgical cutting guide system. Other embodiments describe a cutting tool with a selectively changeable length of the cutting profile of the wire cutting member. In one embodiment, the wire cutting member of the cutting tool is energized by mechanical energy in the form of a unidirectional rotation of the cutting member, a mechanical vibration of the cutting member, or an oscillating movement of the wire cutting member.

A method of inserting and positioning an intervertebral spacer is provided. The spacer includes a longitudinal axis, an on-axis interface coincident with or parallel to the longitudinal axis, and an off-axis interface angled to the longitudinal axis. The spacer's front end may be curved. The method may include inserting the spacer into the disc space utilizing a tool to engage an on-axis interface and then to engage one or more of the off-axis interfaces, which may be used for further modification of the spacer. The tool is moved substantially along a single insertion direction, which may be substantially parallel to a posterior-anterior axis of the disc space. The method may result in the longitudinal axis of the spacer being perpendicular to the insertion direction, or substantially parallel to a medial-lateral axis of the disc space. The spacer may also be positioned in an anterior aspect of the disc space.

Computer modeling of interactions between and among cortico and subcortical areas of the human brain, for example in a normal and a pathological state resembling schizophrenia which pathological state has inputs representing the effects of a drug(s), for the purpose of using the outputs to predict the effect of drugs in psychiatric and cognitive diseases on one or more clinical scales. Diseases that can be modeled include psychiatric disorders, such as schizophrenia, bipolar disorder, major depression, ADHD, autism, obsessive-compulsive disorder, substance abuse and cognitive deficits therein and neurological disorders such as Alzheimer's disease, Mild Cognitive impairment, Parkinson's disease, stroke, vascular dementia, Huntington's disease, epilepsy and Down syndrome. The computer model preferably uses the biological state of interactions between and among cortico and subcortical areas of the human brain, to define the biological processes related to the biological state of the generic synapse model, the striatum, Locus Coeruleus, Dorsal raphe, hippocampus, amygdala and cortex, as well as certain mathematical relationships related to interactions among biological variables associated with the biological processes.

The invention discloses a method of administering a pharmaceutical combination comprising an NSAID and a slow release tramadol to a mammal in need of thereof. This invention further discloses an analgesic combination comprising an NSAID and a slow release tramadol for treating pain and pain related conditions.

A method for implanting a longitudinal intramedullary nail into the tibia comprises inserting the tibia nail along a plane of symmetry through the tuberositas tibiae. Thereby, the tuberositas tibiae can be used during nail insertion to correctly align the nail and the target arm to the symmetry plane of the bone. This means, that the whole construct, the nail attached to the target arm, has to be inserted in external rotation.

Multi-level spinal stabilization devices, systems and methods are provided that include at least one multi-level connector, one elongated member with an enlarged head, at least one pedicle screw, and at least one mechanism that supports three degrees of rotational freedom relative to both the elongated member and the pedicle screw each. The mechanism may include universal joint mechanisms or ball and socket mechanisms. In the case of the ball and socket mechanisms, the enlarged head of the elongated member cooperates with a first socket member of the multi-level connector to define a dynamic junction that allows the socket member to move relative to the enlarged head of the elongated member while remaining engaged therewith.

The invention is a novel adaptive CT-compatible brachytherapy applicator with remotely-controlled radial and longitudinal motion radioactive source lumen shields that can be manipulated by the radiation oncologist to optimize the dose distribution to the target and normal tissue structures for brachytherapy procedures.